IAPAC / BHIVA Conference (Controlling the HIV Epidemic with Antiretrovirals)

Download the programme Download the Abstract book Date: 22 - 24 September 2013

Venue: Queen Elizabeth II Conference Centre, London

The International Association of Providers of AIDS Care (IAPAC) fully embraced two biobehavioral HIV prevention interventions in 2012 – antiretroviral-based treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) – calling for immediate integration of these interventions into the existing HIV armamentarium as a means of significantly curbing HIV incidence worldwide.

IAPAC made the announcement at the AIDS 2012 conference, where it unveiled a Consensus Statement entitled, "Controlling the HIV Epidemic with Antiretrovirals," reflecting consensus reached by delegates of the inaugural Controlling the HIV Epidemic with Antiretrovirals evidence summit held last year in London. Click here to access the 2012 Consensus Statement.

While the concepts of TasP and PrEP have gained formidable ground since 2012, with numerous implementation and operational studies ongoing to investigate their utility, there remains much to learn about and plan for as we prepare for their integration into clinical practice. In addition, there are numerous challenges facing a variety of stakeholders as we seek to achieve the impact these biomedical prevention interventions – as part of a high impact prevention approach – promise in the third decade of the HIV pandemic.

In partnership with the British HIV Association (BHIVA), IAPAC thus hosted its second evidence summit entitled, Controlling the HIV Epidemic with Antiretrovirals: From Consensus to Implementation, September 22-24, 2013, at the Queen Elizabeth II Conference Centre in London. The evidence summit's goal was to provide a venue for the presentation of data related to and discussion about the implementation of TasP and PrEP in a variety of clinical settings.

An important global deliverable from this summit will be a follow-up Consensus Statement outlining key TasP and PrEP implementation recommendations. The document will be disseminated to IAPAC's 17,000-plus clinician-members in over 100 countries, as well as through our partnerships with national, regional, and international medical and nursing associations worldwide.


Click here to view presentations.

Visit the IAPAC website

Continuing Professional Development

Medical staff in career grade posts who are enrolled with one of the Royal Medical Colleges for Continuing Professional Development will be entitled to receive CPD credits at the rate of one CPD credit per conference hour (exclusive of travel, refreshments, pharmaceutical-supported sessions and social events). The unique reference code for the conference is 83763. The entire conference has been allocated 17 category 1 (external) CPD credits. Please be advised that the attendance list of the conference will be forwarded to the Royal College of Physicians upon request.


Alere, Gilead Sciences, Janssen UK, and ViiV Healthcare have provided educational grants in support of this summit. IAPAC is responsible for control of the summit's content and faculty selection. In awarding educational grants, neither Alere, Gilead Sciences, Janssen UK, nor ViiV Healthcare had any involvement in the design of the program or the selection of presenters, panelists, and/or moderators.